Show
Sort by
-
Non-viral transfection technologies for next-generation therapeutic T cell engineering
-
- Journal Article
- A1
- open access
T cell engaging immunotherapies, highlighting chimeric antigen receptor (CAR) T cell therapy
-
An atypical sarcoid-like reaction during anti-protein death 1 treatment in a patient with metastatic melanoma
-
- Journal Article
- A2
- open access
Psoriasis vulgaris exacerbation during treatment with a PD-1 checkpoint inhibitor : case report and literature review
-
Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma
-
- Journal Article
- A1
- open access
Long non-coding RNAs in cutaneous melanoma : clinical perspectives
-
Immunological, anti-angiogenic and clinical effects of intratumoral interleukin 12 electrogene therapy combined with metronomic cyclophosphamide in dogs with spontaneous cancer : a pilot study
-
Intratumoural interleukin 12 gene therapy stimulates the immune system and decreases angiogenesis in dogs with spontaneous cancer
-
- Journal Article
- A1
- open access
A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma : evaluation of clinical and immunologic response
-
Immunogenic apoptotic cell death and anticancer immunity
-
Imaging patterns of metastatic melanoma
-
Fractionated radiotherapy with 3 x 8 Gy induces systemic anti-tumour responses and abscopal tumour inhibition without modulating the humoral anti-tumour response
-
Melanoma-associated leukoderma and vitiligo cannot be differentiated based on blinded assessment by experts in the field
-
- Journal Article
- A1
- open access
Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients
-
- Journal Article
- A1
- open access
Ipilimumab, not just another anti-cancer therapy: hypophysitis as side effect illustrated by four case-reports
-
- Journal Article
- A1
- open access
A personalized view on cancer immunotherapy
-
- Journal Article
- A1
- open access
TCR gene transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 epitopes as melanoma-specific immune targets
-
MDM4 is a key therapeutic target in cutaneous melanoma
-
Halo naevi with associated vitiligo-like depigmentations: pathogenetic hypothesis
-
Prognostic value of serial blood S100B determinations in stage IIB-III melanoma patients: a corollary study to EORTC trial 18952
-
Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy
-
EGFR in melanoma : clinical significance and potential therapeutic target
-
Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma